Policies & Research

Cutting Out Hep B with ‘Molecular Scissors’

A genetic peculiarity that is sometimes found in biochemistry is ‘covalently closed circular DNA‘ (cccDNA), where the DNA molecule, instead of being a long, ribbon-like strand, becomes a closed loop. …

Hep C & Mental Illness: New Link Discovered

The blood–brain barrier is a hugely effective “wall” that protects the brain from pathogens in a person’s body. It’s like a highly selective, very fine sieve that allows vital nutrients …

How Hep B Research Helped when COVID-19 Hit

As the coronavirus spread globally in 2020, and people all around the world began to be uncomfortably familiar with RAT tests and PCR tests, NSW historian Michelle Bootcov realised her …

Progress on Closing the Gap is stagnant or going backwards. Here are 3 things to help fix it

The Productivity Commission’s latest data on Closing the Gap progress represents an unsurprisingly grim overview of the socioeconomic inequalities experienced by Aboriginal and Torres Strait Islander peoples.

Improving Surveillance of Hepatocellular Carcinoma in Australia

The incidence of primary liver cancer in Australia has quadrupled since 1982—faster than any other cancer. Yet, the 5-year survival remains just 22%, in stark contrast to countries like Japan, …

World Hepatitis Day 2025 – It’s Time for Action: Testing Saves Lives

In Australia, there are two diseases which, together, kill nearly 1000 people every year. They affect close to 300,000 people and are also the leading causes of rising liver cancer …

98.9%: The Hepatitis C Cure Rate with Current Direct-Acting Antivirals

When we at Hepatitis SA talk with members of the community about hepatitis C treatment, we usually point out that the current available cure works for more than 95% of …

‘Malhotra Syndrome’: What is it?

A study recently published by a gastroenterology research team in India, has identified a new ”phobia’ in people who have been cured of hepatitis C – the fear of reinfection. …

Experimental Hep B Treatments: Good & Bad News

Two different experimental hepatitis B virus (HBV) treatments have shown very different results in their phase 2 trials in recent weeks. One, while initially promising, has failed to show high …

A Promising New Approach to Treating Potentially Deadly Liver Disease

An experimental new treatment is showing early promise in the fight against liver fibrosis – a serious condition that affects millions.

Transforming Hepatitis B Care: WHO Takes the Lead

Momentum is growing to simplify and expand treatment criteria so that more people with chronic hepatitis B will be treated.

Pat Dodson Urges PM to Act on Reconciliation

Former Labor senator Pat Dodson, sometimes called ‘the Father of Reconciliation’, has emerged from a self-imposed silence to urge the prime minister to take up the cause once more with …

Beating Cancer Through Hepatitis Elimination

Despite having all the tools to combat liver cancer, a lack of prioritisation and action has resulted in an increase in mortality worldwide. These deaths are entirely preventable if people …

The Hepatitis Delta Global Landscape

WHA calls for hepatitis delta educational programs for community-based organisations and policymakers